Intuitive Surgical, Inc (ISRG) presents an intriguing perspective in the world of Artificial Intelligence and robotics in healthcare. With a consistent upwards trend, ISRG has caught the eyes of notable market influencers such as
Rathbones Group and
BlackRock, both increasing their stakes in the company.
Jim Cramer urges those interested in robotics to also consider this robust stock, thanks to an impressive 80% growth. The addition of FDA approved
Da Vinci 5 to its portfolio has propelled the company to new 52-week highs. Encouraging quarterly earnings reports, with beats in both Q1 and Q2, suggest a strong financial performance underpinning their remarkable market growth. This momentum coupled with robust procedural results seems to consolidate its reputation as a leader in the medical AI sector. Their pioneering robotic surgery technology sits favorably with Wall Street analysts, asserting
ISRG as a 'Best of Breed' stock. However, investors should also be aware of occasional market dips, reportedly more significant than the broader market.
Intuitive Surgical ISRG News Analytics from Wed, 10 Jan 2024 08:00:00 GMT to Sun, 15 Sep 2024 12:04:57 GMT -
Rating 8
- Rumor 7
